EA
MIRM icon

Emerald Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History

Emerald Advisers’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.8M Buy
468,295
+71,032
+18% +$7.13M 1.29% 21
2026
Q1 		$36.7M Buy
397,263
+30,129
+8% +$2.83M 1.16% 23
2025
Q4 		$29M Sell
367,134
-2,466
-0.7% -$177K 0.89% 47
2025
Q3 		$27.1M Buy
369,600
+63,834
+21% +$4.06M 0.87% 43
2025
Q2 		$15.6M Buy
+305,766
New +$13.6M 0.57% 71

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Emerald Advisers's MIRM Position: Q2 2026 in Review

Emerald Advisers increased its Mirum Pharmaceuticals (MIRM) stake by 18% in Q2 2026, buying an estimated $7.13M and bringing the position to 468,295 shares worth $54.8M. The position accounts for 1.29% of the portfolio, ranked #21.

Emerald Advisers first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Emerald Advisers held 468,295 shares of Mirum Pharmaceuticals worth $54.8M as of Q2 2026.
  • Emerald Advisers bought 71,032 Mirum Pharmaceuticals shares in Q2 2026, an estimated $7.13M.
  • Mirum Pharmaceuticals made up 1.29% of Emerald Advisers's portfolio in Q2 2026, its #21 holding.
  • Emerald Advisers first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.